MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Multimodal model of Parkinson’s disease highlights differences in progression profiles of RBD patients

    R. Couronné, A. Valladier, M. Vidailhet, J.C Corvol, S. Lehericy, S. Durrleman (Paris, France)

    Objective: To compare subgroups of patients with Parkinson’s disease (PD) with and without rapid eye movement sleep behavior disorders (RBD), in terms of progression speed,…
  • MDS Virtual Congress 2020

    White Matter Changes and Early Cognitive Impairment in Parkinson’s Disease

    T. Belal, S. Elgamal (Mansoura, Egypt)

    Objective: Studying white matter changes in Parkinson's disease patients using diffusion tensor imaging; and its relation to cognition and motor symptoms impairment. Background: Cognitive dysfunction…
  • MDS Virtual Congress 2020

    Regional cortical thickness alterations in PD patients with cognitive impairment

    V. Goyal, S. Chaudhary, A. Ankeeta, S. Kumaran, P. Bhat (New Delhi, India)

    Objective: To evaluate the cortical thickness alterations in cognitively impaired patients with PD (PD-CI) in a comparative study with cognitively normal patients with PD (PD-CN)…
  • MDS Virtual Congress 2020

    Both Symptomatic and Asymptomatic Orthostatic Hypotension is Associated with Cognitive Decline Over Time in Parkinson’s Disease

    K. Longardner, E. Bayram, I. Litvan (San Diego, CA, USA)

    Objective: To compare cognitive changes over time between Parkinson's disease (PD) patients with orthostatic hypotension (OH) and without OH, and between those with symptomatic OH…
  • MDS Virtual Congress 2020

    The feasibility of cognitive telerehabilitation in patients with Parkinson´s disease: The pilot data

    V. Plzáková (Prague, Czech Republic)

    Objective: The aim of this study was to focus on the feasibility and potential benefits of cognitive telerehabilitation (CTR) in patients with Parkinson´s disease (PD).…
  • MDS Virtual Congress 2020

    The relationship between neuromelanin-sensitive MRI, [123I] meta-iodobenzylguanidine scintigraphy and cognition, in patients with Parkinson’s disease

    T. Utsunomiya, K. Matsuura, Y. Ii, A. shindo, m. Umino, M. Maeda, H. Tomimoto (Tsu Mie, Japan)

    Objective: We investigate the relationship  between the contrast ratio of locus coeruleus (LC-CR) in neuromelanin-sensitive MRI(NMI), MIBG scintigraphy, and cognition/hallucination, in patients with Parkinson’s disease.…
  • MDS Virtual Congress 2020

    An introduction to the Global Parkinson’s Genetics Program (GP2)

    C. Blauwendraat, E. Riley, A. Singleton (Bethesda, MD, USA)

    Objective: Expanding the current understanding of the genetic architecture of Parkinson’s disease (PD), accelerate discovery and validation of novel disease-causing genetic mutations and provide training…
  • MDS Virtual Congress 2020

    Apolipoprotein E ε4 and risk of freezing of gait in early Parkinson’s disease

    R. Kim, J.S Jun, H.J Kim, B.S Jeon (Incheon, Republic of Korea)

    Objective: To investigate the association between Apolipoprotein E (APOE) genotype and freezing of gait (FOG) in Parkinson’s disease (PD). Background: This cohort study using the…
  • MDS Virtual Congress 2020

    A novel likely pathogenic SNCA variant associated with Parkinson’s disease

    B. Minafra, G. Buongarzone, S. Gana, M.L Valente, I. Palmieri, T. Biagini, M. Plumari, M. Avenali, R. Zangaglia, T. Mazza, C. Cereda, C. Pacchetti, E.M Valente (Pavia, Italy)

    Objective: To report a novel SNCA likely pathogenic variant. Background: The A53T mutation in the SNCA gene, encoding alpha-synuclein (a-syn), was the first established genetic…
  • MDS Virtual Congress 2020

    mRNA level and variants of the SCARB2 gene in the pathogenesis of Parkinson’s disease

    T. Usenko, A. Bezrukova, D. Bogdanova, A. Kopytova, A. Emelyanov, I. Miliukhina, A. Timofeeva, S. Pchelina (Gatchina, Russian Federation)

    Objective: The aim was to test an association of rs6812193 and rs8475 of the SCARB2 gene with Parkinson’s disease (PD) in case–control study in Russia.…
  • « Previous Page
  • 1
  • …
  • 102
  • 103
  • 104
  • 105
  • 106
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley